Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

RADIAN 2.0 INNOVATION CHALLENGE FUND

Elton John AIDS Foundation

Elton John AIDS Foundation (“the Foundation”), in partnership with Gilead Sciences, launched the groundbreaking initiative “RADIAN” in September 2019 to meaningfully address new HIV infections and deaths from AIDS-related illnesses in Eastern Europe and Central Asia (EECA). RADIAN focuses on action, investment, and resources to improve the quality of life, prevention, and care for people at risk of or living with HIV in the region. The Elton John AIDS Foundation and Gilead have an established presence in EECA and extensive experience working effectively with key local stakeholders in the region, including through the EECA Key Populations Fund that was active in 2017–2020.

RADIAN 2.0 implemented in 2024-2028 is an opportunity to build on these achievements while tackling recently emerged challenges to end the HIV epidemic in the EECA region.

RADIAN 2.0 continues to focus on 25 countries of the EECA region: Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Kazakhstan, Kosovo, Kyrgyzstan, Latvia, Lithuania, Moldova, Montenegro, North Macedonia, Romania, Russian Federation, Serbia, Slovenia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan.

Funding is provided through grants, which are assessed and administered by the Elton John AIDS Foundation. Gilead has no involvement in the selection and assessment of award applicants and winners.

The Innovation Challenge Fund operating within the RADIAN 2.0 program, is designed to foster innovations that have the potential to transform approaches along the HIV care cascade or create an enabling environment that make HIV services more effective. Focused on EECA, this Fund addresses HIV as a significant and ongoing public health issue requiring novel solutions and community-driven support.

The purpose of the Innovation Challenge Fund is to create opportunities for novel ideas addressing the HIV epidemic in EECA to be piloted, evaluated, documented, and if successful, disseminated and replicated. We are inspired by successful examples of healthcare innovation worldwide and are eager to foster similar achievements in the EECA region. We are looking for innovative projects that will improve the quality of life, access to services and their quality for people living with HIV and key populations (KPs) affected by HIV. The Innovation Challenge Fund encourages potentially scalable projects that have a plausible theory of change yet lack evidence of effectiveness in EECA or elsewhere.

This opportunity is open when announced and will remain open until June 30, 2027.

Specialties

International Opportunities

Medical - Clinical Science

Social Sciences

Medical

Medical - Translational

Eligibility Requirements

We encourage Concept Notes from non-profit, academic and research organisations. We will consider Concept Notes from commercial entities if their participation is justified and there is no profit included into the project budget. Ineligible entities include individuals and governments.

Applicants with more than one project idea may submit multiple Concept Notes. Please note each idea requires a separate Concept Note. Applicants may submit Concept Notes under the Innovation Challenge Fund until the call is closed.

Sponsor Details

Sponsor Institute/Organizations: Elton John AIDS Foundation

Sponsor Type:

Address: NA

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity